Focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. This book explores differences in the contemporary systems for evaluating drugs, and medical devices. It is useful for policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.